Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.69) per share. This is a 6.15 percent decrease over losses of $(0.65) per share from the same period last year.
Humana, Eli Lilly And A Major Mining Stock On CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. (NYSE: FCX), adding that she likes the stock
